Skip to content
NBDC Human Database

No datasets in the cart.

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Research ID

hum0291-v1Release info

This page is a past version (v1). The latest version is v2.
Latest version (v2)

Research title

Elucidation of molecular mechanisms of tumorigenesis and development of diagnoses and treatments based on comprehensive genomic analyses in pancreatic tumors, duodenal tumors and biliary tumors

Research overview

Aims
To investigate the molecular mechanisms of tumorigenesis based on the comprehensive genome profiling in pancreatic tumors, duodenal tumors, and biliary tumors
Methods
Genomic DNA was extracted from frozen tissues using QIAamp DNA Mini Kit for whole-genome sequencing (WGS) or from FFPE tissues using QIAamp DNA FFPE Tissue Kit for whole-exome sequencing (WES). For WGS, short-fragment libraries (insert size 350 bp) were prepared with 1-2 μg aliquots of genomic DNA from tumor and matched non-neoplastic tissues using a TruSeq DNA PCR-Free Library Prep Kit according to the manufacturer's instructions. Paired-end sequencing of the libraries was performed using a HiSeq 2000/2500 sequencer. Whole-exome capture libraries were prepared from tumor and matched non-tumor DNAs using a TruSeq Exome Library Prep Kit, according to the manufacturer's instructions. DNA libraries were sequenced in a paired-end mode with 100-bp reads, using HiSeq 2000/2500 sequencer. Total RNA was extracted from frozen tissues using Illustra RNAspin Mini RNA Isolation Kit. Whole-transcriptome sequencing libraries were prepared using the TruSeq RNA Access Library Prep Kit. Sequencing was performed on HiSeq 2500 sequencer.
Participants/materials
Pancreatic tumor, Duodenal tumor, Biliary tumors

Datasets

The list is the one this version published; each dataset's content is shown as it is now.

CartDataset IDType of dataAnalysis methodAccess criteriaDate published
JGAD000473NGS (WGS, Exome)
  • WGS
  • WES
  • RNA-seq
Controlled-access (Type I)2021-12-10

Data provider

Principal investigator
Shinichi Yachida
Affiliation
Cancer Genome Informatics, Department of Genome Biology, Graduate School of Medicine/Faculty of Medicine, Osaka University

Research projects

NameURL
Elucidation of molecular mechanisms of tumorigenesis and development of diagnoses and treatments based on comprehensive genomic analyses in pancreatic tumors, duodenal tumors and biliary tumors
N/A

Grants

NameTitleProject number
Project for Cancer Research and Therapeutic Evolution (P-CREATE), Japan Agency for Medical Research and Development (AMED)
Comprehensive genomic characterization of gastroenterological neuroendocrine carcinomas
  • JP17cm0106612

Related publications

TitleDOIDataset ID
Comprehensive Genomic Profiling of Neuroendocrine Carcinomas of the Gastrointestinal System

Controlled access users

Principal investigatorAffiliationCountry/RegionResearch titlePeriod of data useDataset ID
Auzsa TanimotoDivision of Medical Oncology, Cancer Research Institute, Kanazawa UniversityJapanStrategy for large cell neuroendocrine carcinoma based on gene and molecular subtypes2022-04-07 – 2023-10-04
Takuya YamamotoCenter for Intractable Diseases and ImmunoGenomics, National Institutes of Biomedical Innovation, Health and NutritionJapanBasic research for vaccine development against gastrointestinal cancer and malignant melanoma based on the identification of novel cancer antigens 2024-11-12 – 2026-03-31
Eriko KatsutaHBP surgery, Institute of Science TokyoJapanInvestigation of biomarkers and clinical indicators for early detection, progression, prognosis, and treatment response in hepatobiliary and pancreatic cancers.2025-07-03 – 2027-05-31